These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 15237371)

  • 21. Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study.
    Ghiggeri GM; Catarsi P; Scolari F; Caridi G; Bertelli R; Carrea A; Sanna-Cherchi S; Emma F; Allegri L; Cancarini G; Rizzoni GF; Perfumo F
    Clin Ther; 2004 Sep; 26(9):1411-8. PubMed ID: 15531003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of liver transplantation and cyclosporine on bile formation and lipid composition: an experimental study in the rat.
    Chan FK; Zhang Y; Lee SS; Shaffer EA
    J Hepatol; 1998 Feb; 28(2):329-36. PubMed ID: 9514546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nephrotoxic effects of immunosuppressant therapy in pediatric liver transplant recipients.
    McCulloch MI; Burger H; Spearman CW; Cooke L; Goddard E; Gajjar P; Numanoglu A; Rode H; Kahn D; Millar AJ
    Transplant Proc; 2005 Mar; 37(2):1220-3. PubMed ID: 15848675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
    Choudhry S; Bagga A; Hari P; Sharma S; Kalaivani M; Dinda A
    Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short- and long-time effects of pediatric liver transplantation on serum cholesterol and triglyceride levels--the Vienna cohort.
    Becker J; Huber WD; Aufricht C
    Pediatr Transplant; 2008 Dec; 12(8):883-8. PubMed ID: 18643911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conversion from cyclosporine microemulsion to tacrolimus in stable kidney transplant patients with hypercholesterolemia is related to an improvement in cardiovascular risk profile: a prospective study.
    Marcén R; Chahin J; Alarcón A; Bravo J
    Transplant Proc; 2006 Oct; 38(8):2427-30. PubMed ID: 17097957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal function outcome in pediatric liver transplant recipients.
    Mention K; Lahoche-Manucci A; Bonnevalle M; Pruvot FR; Declerck N; Foulard M; Gottrand F
    Pediatr Transplant; 2005 Apr; 9(2):201-7. PubMed ID: 15787794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective monitoring of lipid profiles in children receiving pravastatin preemptively after renal transplantation.
    Butani L
    Pediatr Transplant; 2005 Dec; 9(6):746-53. PubMed ID: 16269046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term results of kidney transplantation with cyclosporine- and everolimus-based immunosuppression.
    Iaria G; Pisani F; Iorio B; Lucchesi C; De Luca L; Ielpo B; D'Andria D; Tariciotti L; Tisone G
    Transplant Proc; 2006 May; 38(4):1018-9. PubMed ID: 16757249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and effects on the lipid and C-reactive protein plasma concentration of the association of ezetimibe plus atorvastatin in renal transplant patients treated by cyclosporine-A: a pilot study.
    Panichi V; Manca-Rizza G; Paoletti S; Taccola D; Consani C; Sbragia G; Mantuano E; Marchetti V; Carpi A; Barsotti G
    Biomed Pharmacother; 2006 Jun; 60(5):249-52. PubMed ID: 16740374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
    Levy G; Grazi GL; Sanjuan F; Wu Y; Mühlbacher F; Samuel D; Friman S; Jones R; Cantisani G; Villamil F; Cillo U; Clavien PA; Klintmalm G; Otto G; Pollard S; McCormick PA
    Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small dense low-density lipoprotein in renal transplant recipients: a potential target for prevention of cardiovascular complications?
    Badiou S; Garrigue V; Dupuy AM; Chong G; Cristol JP; Mourad G
    Transplant Proc; 2006 Sep; 38(7):2314-6. PubMed ID: 16980076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac function in children post-orthotopic liver transplantation: echocardiographic parameters and biochemical markers of subclinical cardiovascular damage.
    Shalev A; Nir A; Granot E
    Pediatr Transplant; 2005 Dec; 9(6):718-22. PubMed ID: 16269041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized study comparing cyclosporine with azathioprine one year after renal transplantation-15-year outcome data.
    Joss N; Rodger RS; McMillan MA; Junor BJ
    Transplantation; 2007 Mar; 83(5):582-7. PubMed ID: 17353778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
    Burra P; Senzolo M; Masier A; Prestele H; Jones R; Samuel D; Villamil F
    Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum lipids in children 3 to 5 years after kidney, liver, and heart transplantation.
    Siirtola A; Antikainen M; Ala-Houhala M; Koivisto AM; Solakivi T; Jokela H; Lehtimäki T; Holmberg C; Salo MK
    Transpl Int; 2004 Mar; 17(3):109-19. PubMed ID: 14749918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of living donor liver transplant patients using twice-daily 4-hour intravenous cyclosporine therapy.
    Sato K; Iwane T; Sekiguchi S; Nakamura A; Akamatsu Y; Kawagishi N; Miyagi S; Takeda I; Sato A; Fujimori K; Satomi S
    Transplant Proc; 2009; 41(1):229-32. PubMed ID: 19249521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complex feedback regulation of bile acid synthesis in the hamster: the role of newly synthesized cholesterol.
    Scheibner J; Fuchs M; Hörmann E; Stange EF
    Hepatology; 1999 Jul; 30(1):230-7. PubMed ID: 10385661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bile acid synthesis from newly synthesized vs. preformed cholesterol precursor pools in the rat.
    Scheibner J; Fuchs M; Schiemann M; Tauber G; Hörmann E; Stange EF
    Hepatology; 1993 Jun; 17(6):1095-102. PubMed ID: 8514259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of plasma lipid on pharmacokinetics of ciclosporin and its relationship with plasma prednisolone level in renal transplant patients.
    Sugioka N; Kokuhu T; Okamoto M; Yoshimura N; Ito Y; Shibata N; Takada K
    J Pharm Pharmacol; 2006 Sep; 58(9):1193-200. PubMed ID: 16945177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.